Table 1 |
|||
|
Components of cosmetics applied to the underarm and breast area |
|||
|
Component |
Mechanism of action |
Examples of compounds used |
Compounds with known oestrogenic activity |
|
|
|||
|
Antiperspirant |
Mediates formation of a physical plug at the top of the sweat duct to prevent sweat escaping onto the skin surface |
Mainly aluminium salts, often as aluminium chlorhydrate |
Aluminium is a metalloestrogen |
|
Deodorant |
To mask, modify or prevent body odour. Since undesirable smell is generated through the action of bacteria on the sweat on the skin surface, antimicrobial agents act to kill bacteria |
Phenolic compounds, often chlorinated such as triclosan |
Triclosan |
|
Preservative |
To prevent growth of microorganisms during product storage |
Alkyl esters of p-hydroxybenzoic acid (parabens) |
Methylparaben, ethylparaben, n-propylparaben, n-butylparaben, isobutylparaben benzylparaben |
|
Fragrance/fragrance fixer |
To give a good scent to the consumer product |
Synthetic musks, including nitromusks and polycyclic musks. Benzyl salicylate, benzyl benzoate, butylphenymethylpropional (Lilial) |
Polycyclic musks HHCB, AHTN. Nitromusks musk xylene, musk ketone. Benzyl salicylate, benzyl benzoate, butylphenylmethylpropional |
|
Spreading/conditioning |
To ensure even distribution of components across the skin surface |
Linear (dimethicone) and cyclic (cyclomethicone) siloxanes |
Octamethylcyclotetrasiloxane |
|
Plasticiser |
Solvent, moisturiser, fragrance carrier |
Phthalates |
Dibutylphthalate, di(2-ethylhexyl)phthalate, diethylphthalate, butylbenzylphthalate |
|
Surfactant |
For cleansing purposes |
Alkyl phenols |
Nonylphenol |
|
UV filter |
Chemicals act to absorb UVA and UVB light. Also added to aid product stability |
Organic compounds, often benzophenone derivatives |
Benzophenone-3, benzophenone-2, octyl-methoxycinnamate, 3-(4-methylbenzylidene)-camphor, homosalate, octyl-dimethyl-p-aminobenzoic acid |
|
|
|||
|
For references refer to published reviews [5-7]. HHCB, 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8,-hexamethylcyclopenta-γ-2-benzopyran; AHTN, 6-acetyl-1,1,2,4,4,7-hexamethylteralin. |
|||
|
Darbre Breast Cancer Research 2009 11(Suppl 3):S5 doi:10.1186/bcr2424 |
|||